DE112005002912A5 - Pharmazeutisches Mittel umfassend Aminosäuren, Peptide, Proteine und/oder deren Bruchteile und Fragmente und deren Verwendung zur Prophylaxe und Behandlung von Defekten des Immunsystems bei Menschen und Tieren - Google Patents
Pharmazeutisches Mittel umfassend Aminosäuren, Peptide, Proteine und/oder deren Bruchteile und Fragmente und deren Verwendung zur Prophylaxe und Behandlung von Defekten des Immunsystems bei Menschen und Tieren Download PDFInfo
- Publication number
- DE112005002912A5 DE112005002912A5 DE112005002912T DE112005002912T DE112005002912A5 DE 112005002912 A5 DE112005002912 A5 DE 112005002912A5 DE 112005002912 T DE112005002912 T DE 112005002912T DE 112005002912 T DE112005002912 T DE 112005002912T DE 112005002912 A5 DE112005002912 A5 DE 112005002912A5
- Authority
- DE
- Germany
- Prior art keywords
- prophylaxis
- peptides
- fractions
- fragments
- humans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241001465754 Metazoa Species 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 title 1
- 230000007547 defect Effects 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 210000000987 immune system Anatomy 0.000 title 1
- 239000008177 pharmaceutical agent Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 238000011282 treatment Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/15—Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Rolling Contact Bearings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04090376.7 | 2004-09-24 | ||
US10/948,753 US20060067942A1 (en) | 2004-09-24 | 2004-09-24 | Pharmaceutical agent comprising amino acids, peptides, proteins and/or fractions and fragments thereof and the use of same in the prophylaxis and treatment of immune system deficiency in humans and animals |
US10/948,753 | 2004-09-24 | ||
EP04090376A EP1640012A1 (de) | 2004-09-24 | 2004-09-24 | Pharmazeutisches Mittel enthaltend Blutbestandteile 10 kDa und deren Verwendung zur Prophylaxe und Behandlung von Defekten des Immunsystems |
PCT/DE2005/001729 WO2006032269A2 (de) | 2004-09-24 | 2005-09-26 | Pharmazeutisches mittel enthaltend blutbestandteile und oder kda und deren verwendung zur prophylaxe und behandlung von defekten des immunsystems |
Publications (1)
Publication Number | Publication Date |
---|---|
DE112005002912A5 true DE112005002912A5 (de) | 2007-08-30 |
Family
ID=36051574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE112005002912T Withdrawn DE112005002912A5 (de) | 2004-09-24 | 2005-09-26 | Pharmazeutisches Mittel umfassend Aminosäuren, Peptide, Proteine und/oder deren Bruchteile und Fragmente und deren Verwendung zur Prophylaxe und Behandlung von Defekten des Immunsystems bei Menschen und Tieren |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1796695A2 (de) |
JP (1) | JP2008514556A (de) |
AU (1) | AU2005287727A1 (de) |
BR (1) | BRPI0517349A (de) |
CA (1) | CA2580192A1 (de) |
DE (1) | DE112005002912A5 (de) |
MX (1) | MX2007003489A (de) |
WO (1) | WO2006032269A2 (de) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1507215A (en) * | 1975-08-19 | 1978-04-12 | Green Cross Corp | Processes for producing immunoregulatory preparations |
HU182087B (en) * | 1980-01-15 | 1983-12-28 | Mta Kiserleti Orvostudomanyi K | Process for preparing an active substance for the selective inhibition of the multiplication of normal cells and of cells in myeloide leukemia |
IN161706B (de) * | 1983-10-05 | 1988-01-16 | Solco Basel Ag | |
RU2055589C1 (ru) * | 1992-08-21 | 1996-03-10 | Левон Никитович Мкртчян | Способ получения биологически активного вещества, обладающего противоопухолевой, иммуномодулирующей и интерфероногенной активностью |
-
2005
- 2005-09-26 WO PCT/DE2005/001729 patent/WO2006032269A2/de active Application Filing
- 2005-09-26 BR BRPI0517349-3A patent/BRPI0517349A/pt not_active IP Right Cessation
- 2005-09-26 CA CA002580192A patent/CA2580192A1/en not_active Abandoned
- 2005-09-26 MX MX2007003489A patent/MX2007003489A/es not_active Application Discontinuation
- 2005-09-26 JP JP2007532768A patent/JP2008514556A/ja not_active Withdrawn
- 2005-09-26 EP EP05800702A patent/EP1796695A2/de not_active Withdrawn
- 2005-09-26 AU AU2005287727A patent/AU2005287727A1/en not_active Abandoned
- 2005-09-26 DE DE112005002912T patent/DE112005002912A5/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2006032269A2 (de) | 2006-03-30 |
MX2007003489A (es) | 2007-05-18 |
AU2005287727A1 (en) | 2006-03-30 |
BRPI0517349A (pt) | 2008-10-07 |
CA2580192A1 (en) | 2006-03-30 |
EP1796695A2 (de) | 2007-06-20 |
WO2006032269A3 (de) | 2006-06-15 |
JP2008514556A (ja) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60221051D1 (de) | Herstellung von peptiden und proteinen durch anhäufung in vom endoplasmatischen reticulum abgeleiteten proteinkörpern | |
ATE198050T1 (de) | Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia | |
WO2004074486A3 (en) | Fusion proteins of interferon alpha muteins with improved properties | |
NO20045521L (no) | Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer | |
ATE389649T1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
ATE542801T1 (de) | Zur behandlung von neoplastischen krankheiten, entzündlichen erkrankungen und erkrankungen des immunsystems geeignete 2,4-pyrimidindiamine | |
DE69835279D1 (de) | Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika | |
IL171991A0 (en) | Use of an interferon polypeptide in the preparation of a pharmaceutical composition for treating virus infection and a method of treating a virus-infected non human subject | |
DE60130791D1 (de) | Amphiphile lipid-nanopartikel zur peptid- und/oder proteininkorporation | |
HRP20140888T1 (hr) | Humana monoklonalna protutijela za humani il-4 | |
IL222879A (en) | Peptides and their use in the treatment and diagnosis of diseases and pharmaceutical preparations containing them | |
EP2537524A3 (de) | Behandlung von T-Zell-vermittelten Krankheiten | |
DE69412243D1 (de) | Biologisch aktive peptide aus funktionellen domaenen des bakteriziden/ die permeabilitaet erhoehenden proteins und ihre verwendung | |
DE50004018D1 (de) | Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen | |
ATE362928T1 (de) | 2-(1h-indazol-6-ylamino)- benzamid-verbindungen als protein kinase inhibitoren und deren verwendung zur behandlung von ophthalmischen krankheiten | |
DE69719754D1 (de) | Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung | |
DE602005013650D1 (de) | Proteinhydrolysat zur behandlung von müdigkeit | |
ATE401400T1 (de) | Antiangiogene peptide zur behandlung oder vorbeugung von endometriose | |
DE69838667D1 (de) | Verfahren zur stabilisierung nützlicher proteine und nützliche proteinhaltige mittel | |
DE60303735D1 (de) | Flüssiges Konzentrat zur Konservierung kosmetischer und pharmazeutischer Produkte | |
DK1636261T3 (da) | Thrombopoietinproteiner med forbedrede egenskaber | |
DE112005002912A5 (de) | Pharmazeutisches Mittel umfassend Aminosäuren, Peptide, Proteine und/oder deren Bruchteile und Fragmente und deren Verwendung zur Prophylaxe und Behandlung von Defekten des Immunsystems bei Menschen und Tieren | |
ATE361914T1 (de) | Cathepsincysteinproteaseinhibitoren und deren verwendung zur behandlung von entzündungen und immunerkrankungen | |
ZA200703237B (en) | Pharmaceutical agents comprising blood components <10 KDA and their use for prophylaxis and treatment of defects of the immune system | |
WO2001007479A3 (en) | Fragments of cellular prion protein and methods useful in the diagnosis and treatment of prion diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8139 | Disposal/non-payment of the annual fee |